Regeneron Pharmaceuticals Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $3.65B | $809.1M |
| FY2016 | — | $4.45B | $535.2M |
| FY2017 | — | $6.14B | $812.7M |
| FY2018 | — | $8.76B | $1.47B |
| FY2019 | $0 | $11.09B | $1.62B |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $3.65B | $809.1M |
| FY2016 | — | $4.45B | $535.2M |
| FY2017 | — | $6.14B | $812.7M |
| FY2018 | — | $8.76B | $1.47B |
| FY2019 | $0 | $11.09B | $1.62B |